login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
All US stocks
All Canadian stocks
All European stocks
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Account
Disclaimer
Affiliate
Contact
Privacy
RAIN ENHANCEMENT TECHNO-CL A (RAIN) Stock News
NASDAQ:RAIN - Nasdaq -
US75080J1034
-
Common Stock
- Currency: USD
3.7737
+0 (+0.1%)
Summary
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
RAIN Latest News, Press Relases and Analysis
All
Press Releases
a month ago - By: Benzinga
- Mentions:
HTCO
CREG
GLBS
SGBX
...
12 Industrials Stocks Moving In Tuesday's After-Market Session
2 months ago - By: Benzinga
- Mentions:
OESX
NCL
NCRA
UAVS
...
12 Industrials Stocks Moving In Wednesday's Intraday Session
6 months ago - By: Rain Enhancement Technologies Holdco, Inc.
Rain Enhancement Technologies Holdco, Inc. Announces Management Updates and Appointment of Randy Seidl as Chief Executive Officer
1 years ago - By: Pathos AI, Inc.
Pathos AI Completes Acquisition of Rain Oncology
2 years ago - By: Kahn Swick & Foti, LLC
RAIN ONCOLOGY INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Rain Oncology Inc. - RAIN
2 years ago - By: Brodsky & Smith LLC
- Mentions:
ABBV
AZN
CERE
CNSL
...
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Icosavax, Inc. (Nasdaq - ICVX), Rain Oncology, Inc. (Nasdaq – RAIN), Consolidated Communications Holdings, Inc. (Nasdaq - CNSL), Cerevel Therapeutics Holdings, Inc.
2 years ago - By: Brodsky & Smith LLC
- Mentions:
ICVX
CNSL
CERE
AZN
...
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Icosavax, Inc. (Nasdaq - ICVX), Rain Oncology, Inc. (Nasdaq – RAIN), Consolidated Communications Holdings, Inc. (Nasdaq - CNSL), Cerevel Therapeutics Holdings, Inc.
2 years ago - By: Kahn Swick & Foti, LLC
RAIN ONCOLOGY INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Rain Oncology Inc. - RAIN
2 years ago - By: Brodsky & Smith LLC
- Mentions:
AYX
CNSL
CERE
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Alteryx, Inc. (NYSE – AYX), Rain Oncology, Inc. (Nasdaq – RAIN), Consolidated Communications Holdings, Inc. (Nasdaq - CNSL), Cerevel Therapeutics Holdings, Inc.
2 years ago - By: Ademi LLP
Shareholder Alert: Ademi LLP investigates whether Rain Oncology Inc. has obtained a Fair Price in its transaction with Pathos
2 years ago - By: Halper Sadeh LLC
RAIN Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Rain Oncology Inc. Is Fair to Shareholders
2 years ago - By: Seeking Alpha
Rain Oncology to be acquired by Pathos AI for $1.16 in cash per share (NASDAQ:RAIN)
2 years ago - By: Rain Oncology Inc.
Rain Oncology Enters into Agreement to be Acquired by Pathos AI for $1.16 in Cash per Share Plus Contingent Value Rights
2 years ago - By: Rain Oncology Inc.
Rain Oncology Reports Third Quarter 2023 Financial Results and Provides Business Update
2 years ago - By: Rain Oncology Inc.
Rain Oncology Confirms Receipt of Unsolicited Proposal from Concentra Biosciences
2 years ago - By: Seeking Alpha
Rain Oncology gets $1.25/share takeover offer from Tang Capital (NASDAQ:RAIN)
2 years ago - By: Rosen Law Firm, P.A.
ROSEN, A TOP RANKED LAW FIRM, Encourages Rain Oncology Inc. Investors to Secure Counsel Before Important September 12 Deadline in Securities Class Action - RAIN
2 years ago - By: The Law Offices of Frank R. Cruz
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Rain Oncology Inc. (RAIN)
Please enable JavaScript to continue using this application.